TransMedics (TMDX) Net Cash Flow (2018 - 2026)

TransMedics' Net Cash Flow history runs 9 years deep, the most recent figure standing at -$8.4 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 68.87% year-over-year to -$8.4 million in Q1 2026; TTM through Mar 2026 was $168.9 million, a 521.65% increase from a year earlier, with the FY2025 full-year figure at $150.4 million, up 361.07% from the prior year.
• Net Cash Flow declined to -$8.4 million in Q1 2026 per TMDX's latest filing, from $22.1 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $386.8 million in Q2 2023 and bottomed at -$155.2 million in Q3 2023.
• The 5-year median for Net Cash Flow is -$3.7 million (2022), against an average of $26.7 million.
• Across the five-year window, Net Cash Flow jumped 6821.28% in 2022 and tumbled 772.79% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at -$3.7 million in 2022, then tumbled by 772.79% to -$32.6 million in 2023, then jumped by 122.22% to $7.2 million in 2024, then jumped by 205.09% to $22.1 million in 2025, then tumbled by 137.84% to -$8.4 million in 2026.
• Per Business Quant, the three latest TMDX Net Cash Flow figures stand at -$8.4 million (Q1 2026), $22.1 million (Q4 2025), and $65.6 million (Q3 2025).